CartaBio

Recent Finacing

Equity

Recent Raise

Undisclosed

CartaBio develops spatial-omics technologies including the SAFE live‑cell fluorescence imaging platform for multiplexed, longitudinal biomarker analysis in live cells/tissues, and a multimodal CellBERT large‑model to support applications.